CSIMarket
 


International Stem Cell Corporation  (ISCO)
Other Ticker:  
 


International Stem Cell's Gross Profit Margin by quarter

Trends, Rankings, Statistics



ISCO Gross Profit Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change 15.85 % -9.18 % 3.27 % 31.85 % -7.55 %
Seq. Revenue Change 7.17 % -11.74 % -14.16 % 42.69 % -15.98 %
Revenue In Millions $1.97 $1.84 $2.09 $2.43 $1.70
Gross Profit Margin 60.42 % 61.27 % 60.5 % 53.25 % 59.48 %
Gross Profit Margin Total Ranking # 2079 # 2157 # 2192 # 2774 # 2334
Gross Profit In Millions $1.19 $1.13 $1.26 $1.29 $1.01
Y / Y Gross Profit Change 17.67 % -13.83 % -2.55 % 16.89 % -1.46 %
Seq. Gross Profit Change 5.67 % -10.62 % -2.47 % 27.74 % -22.61 %


Commenting Third Quarter 2023 Gross Profit Margin
International Stem Cell has managed to improve its Revenue sequentially to $2 millions by 7.17 % faster than Gross Profit increase of 5.67 % to $1 millions, this led to contraction in Gross Profit Margin to 60.42 %, below company average.

Observing third quarter 2023 results within Major Pharmaceutical Preparations industry 225 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2079, from total ranking in previous quarter at 2157.
Learn about Gross Margin
ISCO's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 226
Healthcare Sector # 465
Overall # 2074

Gross Profit Margin Statistics
High Average Low
77.42 % 65.48 % 29.63 %
(Jun 30 2013)   (Dec 31 2014)




Other Gross Profit Margin Profitability Ratios
ISCO's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ISCO's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ISCO's Competitors
Gross Profit Margin Profit Margin for International Stem Cell's Suppliers
Gross Profit Margin Profit Margin for ISCO's Customers

You may also want to know
ISCO's Annual Growth Rates ISCO's Profitability Ratios ISCO's Asset Turnover Ratio ISCO's Dividend Growth
ISCO's Roe ISCO's Valuation Ratios ISCO's Financial Strength Ratios ISCO's Gross Profit Growth
ISCO's Roa ISCO's Inventory Turnover Ratio ISCO's Growth Rates ISCO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2023 MRQ Gross ProfitSep 30 2023 MRQ Revenue
Abcellera Biologics Inc   100.00 %$ 6.599 $ 6.599 
Abeona Therapeutics Inc   100.00 %$ 0.593 $ 0.593 
Arbutus Biopharma Corp  100.00 %$ 4.658 $ 4.658 
Alpine Immune Sciences Inc   100.00 %$ 10.043 $ 10.043 
Altimmune Inc   100.00 %$ 0.362 $ 0.362 
Anaptysbio Inc   100.00 %$ 3.318 $ 3.318 
Apellis Pharmaceuticals Inc   100.00 %$ 110.399 $ 110.399 
Aravive Inc   100.00 %$ 2.756 $ 2.756 
Arcturus Therapeutics Holdings Inc   100.00 %$ 45.140 $ 45.140 
Aridis Pharmaceuticals Inc   100.00 %$ 0.417 $ 0.417 
Arvinas Inc   100.00 %$ 34.600 $ 34.600 
Arrowhead Pharmaceuticals Inc   100.00 %$ 16.097 $ 16.097 
Atai Life Sciences N v   100.00 %$ 0.087 $ 0.087 
Axim Biotechnologies Inc   100.00 %$ 0.010 $ 0.010 
Azitra Inc   100.00 %$ 0.311 $ 0.311 
Bicycle Therapeutics Plc  100.00 %$ 5.352 $ 5.352 
Bellicum Pharmaceuticals Inc   100.00 %$ 1.002 $ 1.002 
Bolt Biotherapeutics Inc   100.00 %$ 2.528 $ 2.528 
Capricor Therapeutics inc   100.00 %$ 6.186 $ 6.186 
Carisma Therapeutics Inc   100.00 %$ 3.827 $ 3.827 
Checkpoint Therapeutics Inc   100.00 %$ 0.031 $ 0.031 
Chimerix Inc   100.00 %$ 0.011 $ 0.011 
Cnbx Pharmaceuticals Inc   100.00 %$ 0.100 $ 0.100 
Cns Pharmaceuticals Inc   100.00 %$ 0.013 $ 0.013 
Crinetics Pharmaceuticals Inc   100.00 %$ 0.346 $ 0.346 
Cervomed Inc   100.00 %$ 1.526 $ 1.526 
Cytomx Therapeutics Inc   100.00 %$ 26.384 $ 26.384 
Cue Biopharma Inc   100.00 %$ 2.100 $ 2.100 
Cyclacel Pharmaceuticals Inc   100.00 %$ 0.016 $ 0.016 
Cytokinetics Incorporated  100.00 %$ 0.378 $ 0.378 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com